Monocular patient or patient with a BCVA of 35 or fewer letters (20/200 or worse) in the better seeing eye

Any prior treatment of CNV or advanced AMD in the study eye, except for dietary supplements or vitamins

Any intraocular or ocular surface surgery (including cataract surgery and laser procedures) in the study eye within 3 months

Vitrectomy in the study eye

Hereditary or chronic hemorrhagic or coagulopathy conditions (i.e., hemophilia)

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration